{
    "clinical_study": {
        "@rank": "124491", 
        "acronym": "LLLTHSCT", 
        "arm_group": [
            {
                "arm_group_label": "Low-Level laser (660nm, 40mW, 0.16 J, 4 J/cm2)", 
                "arm_group_type": "Active Comparator", 
                "description": "In the laser group, an indium phosphide, galium and aluminum (InGaAIP) diode laser was used to irradiate oral mucosa. Subjects received the LLLT from the first day of the conditioning regimen and continued until D+7. Laser therapy was applied by a single dentist expertise in laser irradiation. The tip touched the mucosa of the lips, right and left buccal mucosa, right and left lateral tongue, ventral tongue and buccal floor, giving a total of 10 points per region."
            }, 
            {
                "arm_group_label": "Allocated not to receive intervention", 
                "arm_group_type": "No Intervention"
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of the study was to evaluate the effect of low-level laser therapy (LLLT) on the\n      severity of oral mucositis (OM) and inflammatory mediators (pro- and anti-inflammatory\n      cytokines, metalloproteinases and growth factors) levels in saliva and blood of\n      hematopoietic stem cell transplantation (HSCT) patients."
        }, 
        "brief_title": "Low-level Laser Therapy on Inflammatory Mediators During Chemotherapy-induced Oral Mucositis", 
        "completion_date": {
            "#text": "August 2013", 
            "@type": "Actual"
        }, 
        "condition": "Oral Mucositis in Patients Undergoing Hematopoietic Stem Cell Transplantation", 
        "condition_browse": {
            "mesh_term": [
                "Stomatitis", 
                "Mucositis"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Schedule to receive myeloablative conditioning regimens using chemotherapy; oral\n             mucosa lining intact on the first day of the conditioning regimen;\n\n        Exclusion Criteria:\n\n          -  Patients who presented with oral oral ulceration or erosion, active oral, viral,\n             bacterial, or fungal infections on admission, or active oral bleeding which was\n             uncontrollable during laser therapy or had required oral tracheal intubation during\n             hospitalization in the HSCT Unit."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "14 Years"
        }, 
        "enrollment": {
            "#text": "25", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "January 26, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02050373", 
            "org_study_id": "382/2011"
        }, 
        "intervention": {
            "arm_group_label": "Low-Level laser (660nm, 40mW, 0.16 J, 4 J/cm2)", 
            "intervention_name": "Low-Level laser", 
            "intervention_type": "Radiation"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Mucositis", 
            "Stomatitis", 
            "Chemotherapy", 
            "Hematopoietic stem cell transplant", 
            "Laser therapy", 
            "Inflammatory cytokines"
        ], 
        "lastchanged_date": "January 28, 2014", 
        "number_of_arms": "2", 
        "official_title": "Effect of Low-level Laser Therapy on Inflammatory Mediators Release During Chemotherapy-induced Oral Mucositis: a Randomized Preliminary Study", 
        "overall_official": [
            {
                "affiliation": "Universidade Federal de Goias", 
                "last_name": "Geisa B L Silva, Master", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Universidade Federal de Goias", 
                "last_name": "Aline C Batista, Doctor", 
                "role": "Study Director"
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Brazil: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "November 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "description": "A  trained clinical member of the team who was blind to the randomization allocation scores the degree of OM, during the hospitalization, in accordance to the World Health Organization (WHO) mucositis scale as follow: grade 0, no signs or symptoms; grade 1, painless ulcers, erythema, or mild soreness; grade 2, painful erythema, edema, or ulceration but the patient is able to eat; grade 3, mucosal damage and the patient is able to ingest only liquids; and grade 4, severe mucosa damage and the patient requires parenteral or enteral support.", 
                "measure": "Severity of oral mucositis", 
                "safety_issue": "No", 
                "time_frame": "Daily from the day of the transplant (D0) until day 20 (D+20)"
            }, 
            {
                "description": "Patients were instructed to rinse their mouths with pure water and swallow all saliva before collection. The saliva was collected during the early hours of the morning and sterile tubes were used where each patient collected all of the saliva that had formed in the oral cavity for 5 minutes. Samples (5.0 mL) of peripheral blood were taken at the same days as saliva collection using the Vacutainer\u00ae system (Becton Dickinson and Company) with anticoagulant (EDTA).", 
                "measure": "Level of inflammatory mediators", 
                "safety_issue": "No", 
                "time_frame": "At 2 time points before the transplantation (admission and D-1), on days 3 and 7 after transplantation (D+3 and D+7) and on the day of the patient's neutrophil recovery (granulocytes > 500/mm3 for two consecutive days)."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02050373"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Universidade Federal de Goias", 
            "investigator_full_name": "Geisa Badauy Lauria Silva", 
            "investigator_title": "Principal investigator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Universidade Federal de Goias", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Federal University of Minas Gerais", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Araujo Jorge Hospital", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Universidade Federal de Goias", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}